List of Tables
Table 1. Global Hepatic Encephalopathy Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Hepatic Encephalopathy Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Hepatic Encephalopathy Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Hepatic Encephalopathy Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Hepatic Encephalopathy Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Hepatic Encephalopathy Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Hepatic Encephalopathy Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Hepatic Encephalopathy Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Hepatic Encephalopathy Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hepatic Encephalopathy Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hepatic Encephalopathy Drug, Product Type & Application
Table 12. Global Key Manufacturers of Hepatic Encephalopathy Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hepatic Encephalopathy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatic Encephalopathy Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hepatic Encephalopathy Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Hepatic Encephalopathy Drug Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Hepatic Encephalopathy Drug Sales Market Share by Region (2020-2025)
Table 19. Global Hepatic Encephalopathy Drug Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Hepatic Encephalopathy Drug Sales Market Share by Region (2026-2031)
Table 21. Global Hepatic Encephalopathy Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Hepatic Encephalopathy Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Hepatic Encephalopathy Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Hepatic Encephalopathy Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Hepatic Encephalopathy Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Hepatic Encephalopathy Drug Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Hepatic Encephalopathy Drug Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Hepatic Encephalopathy Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Hepatic Encephalopathy Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Hepatic Encephalopathy Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Hepatic Encephalopathy Drug Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Hepatic Encephalopathy Drug Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Hepatic Encephalopathy Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Hepatic Encephalopathy Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Hepatic Encephalopathy Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Hepatic Encephalopathy Drug Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Hepatic Encephalopathy Drug Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Hepatic Encephalopathy Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Hepatic Encephalopathy Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hepatic Encephalopathy Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Hepatic Encephalopathy Drug Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Hepatic Encephalopathy Drug Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Hepatic Encephalopathy Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Hepatic Encephalopathy Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Hepatic Encephalopathy Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Hepatic Encephalopathy Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Hepatic Encephalopathy Drug Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Hepatic Encephalopathy Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Hepatic Encephalopathy Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Hepatic Encephalopathy Drug Sales (K Pcs) by Type (2020-2025)
Table 51. Global Hepatic Encephalopathy Drug Sales (K Pcs) by Type (2026-2031)
Table 52. Global Hepatic Encephalopathy Drug Sales Market Share by Type (2020-2025)
Table 53. Global Hepatic Encephalopathy Drug Sales Market Share by Type (2026-2031)
Table 54. Global Hepatic Encephalopathy Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Hepatic Encephalopathy Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Hepatic Encephalopathy Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Hepatic Encephalopathy Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Hepatic Encephalopathy Drug Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Hepatic Encephalopathy Drug Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Hepatic Encephalopathy Drug Sales (K Pcs) by Application (2020-2025)
Table 61. Global Hepatic Encephalopathy Drug Sales (K Pcs) by Application (2026-2031)
Table 62. Global Hepatic Encephalopathy Drug Sales Market Share by Application (2020-2025)
Table 63. Global Hepatic Encephalopathy Drug Sales Market Share by Application (2026-2031)
Table 64. Global Hepatic Encephalopathy Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Hepatic Encephalopathy Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Hepatic Encephalopathy Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Hepatic Encephalopathy Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Hepatic Encephalopathy Drug Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Hepatic Encephalopathy Drug Price (USD/Pcs) by Application (2026-2031)
Table 70. Alfa Wassermann S.p.A Company Information
Table 71. Alfa Wassermann S.p.A Description and Business Overview
Table 72. Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Product
Table 74. Alfa Wassermann S.p.A Recent Developments/Updates
Table 75. Cosmo Pharmaceuticals S.p.A Company Information
Table 76. Cosmo Pharmaceuticals S.p.A Description and Business Overview
Table 77. Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Product
Table 79. Cosmo Pharmaceuticals S.p.A Recent Developments/Updates
Table 80. Horizon Pharma Plc Company Information
Table 81. Horizon Pharma Plc Description and Business Overview
Table 82. Horizon Pharma Plc Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Horizon Pharma Plc Hepatic Encephalopathy Drug Product
Table 84. Horizon Pharma Plc Recent Developments/Updates
Table 85. KannaLife Sciences, Inc. Company Information
Table 86. KannaLife Sciences, Inc. Description and Business Overview
Table 87. KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Product
Table 89. KannaLife Sciences, Inc. Recent Developments/Updates
Table 90. Ocera Therapeutics, Inc. Company Information
Table 91. Ocera Therapeutics, Inc. Description and Business Overview
Table 92. Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Product
Table 94. Ocera Therapeutics, Inc. Recent Developments/Updates
Table 95. Rebiotix Inc. Company Information
Table 96. Rebiotix Inc. Description and Business Overview
Table 97. Rebiotix Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Rebiotix Inc. Hepatic Encephalopathy Drug Product
Table 99. Rebiotix Inc. Recent Developments/Updates
Table 100. Spherium Biomed S.L. Company Information
Table 101. Spherium Biomed S.L. Description and Business Overview
Table 102. Spherium Biomed S.L. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Spherium Biomed S.L. Hepatic Encephalopathy Drug Product
Table 104. Spherium Biomed S.L. Recent Developments/Updates
Table 105. Umecrine Cognition AB Company Information
Table 106. Umecrine Cognition AB Description and Business Overview
Table 107. Umecrine Cognition AB Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Umecrine Cognition AB Hepatic Encephalopathy Drug Product
Table 109. Umecrine Cognition AB Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Hepatic Encephalopathy Drug Distributors List
Table 113. Hepatic Encephalopathy Drug Customers List
Table 114. Hepatic Encephalopathy Drug Market Trends
Table 115. Hepatic Encephalopathy Drug Market Drivers
Table 116. Hepatic Encephalopathy Drug Market Challenges
Table 117. Hepatic Encephalopathy Drug Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hepatic Encephalopathy Drug
Figure 2. Global Hepatic Encephalopathy Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hepatic Encephalopathy Drug Market Share by Type: 2024 & 2031
Figure 4. RBX-2660 Product Picture
Figure 5. KLS-13019 Product Picture
Figure 6. GR-3027 Product Picture
Figure 7. SYNB-1020 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Hepatic Encephalopathy Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Hepatic Encephalopathy Drug Market Share by Application: 2024 & 2031
Figure 11. Clinic
Figure 12. Hospital
Figure 13. Others
Figure 14. Global Hepatic Encephalopathy Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Hepatic Encephalopathy Drug Market Size (2020-2031) & (US$ Million)
Figure 16. Global Hepatic Encephalopathy Drug Sales (2020-2031) & (K Pcs)
Figure 17. Global Hepatic Encephalopathy Drug Average Price (USD/Pcs) & (2020-2031)
Figure 18. Hepatic Encephalopathy Drug Report Years Considered
Figure 19. Hepatic Encephalopathy Drug Sales Share by Manufacturers in 2024
Figure 20. Global Hepatic Encephalopathy Drug Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Hepatic Encephalopathy Drug Players: Market Share by Revenue in Hepatic Encephalopathy Drug in 2024
Figure 22. Hepatic Encephalopathy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Hepatic Encephalopathy Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Hepatic Encephalopathy Drug Sales Market Share by Country (2020-2031)
Figure 25. North America Hepatic Encephalopathy Drug Revenue Market Share by Country (2020-2031)
Figure 26. U.S. Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Hepatic Encephalopathy Drug Sales Market Share by Country (2020-2031)
Figure 29. Europe Hepatic Encephalopathy Drug Revenue Market Share by Country (2020-2031)
Figure 30. Germany Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Hepatic Encephalopathy Drug Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Hepatic Encephalopathy Drug Revenue Market Share by Region (2020-2031)
Figure 37. China Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Taiwan Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Philippines Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Hepatic Encephalopathy Drug Sales Market Share by Country (2020-2031)
Figure 48. Latin America Hepatic Encephalopathy Drug Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Hepatic Encephalopathy Drug Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Hepatic Encephalopathy Drug Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Hepatic Encephalopathy Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Hepatic Encephalopathy Drug by Type (2020-2031)
Figure 58. Global Revenue Market Share of Hepatic Encephalopathy Drug by Type (2020-2031)
Figure 59. Global Hepatic Encephalopathy Drug Price (USD/Pcs) by Type (2020-2031)
Figure 60. Global Sales Market Share of Hepatic Encephalopathy Drug by Application (2020-2031)
Figure 61. Global Revenue Market Share of Hepatic Encephalopathy Drug by Application (2020-2031)
Figure 62. Global Hepatic Encephalopathy Drug Price (USD/Pcs) by Application (2020-2031)
Figure 63. Hepatic Encephalopathy Drug Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
